3 unchanged sentences
Holders of Common Stock
−Removed: As of February 18, 2022, there were 151 holders of record of our common stock.
+Added: As of February 22, 2023, there were approximately 150 holders of record of our common stock.
The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees.
8 unchanged sentences
under the Securities Act of 1933, as amended (the "Securities Act"), whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
−Removed: The following graph compares the cumulative total return to stockholder return on our common stock relative to the cumulative total returns of the NASDAQ Composite Index and the NASDAQ Biotechnology Index.
+Added: The following graph compares the cumulative total stockholder return on our common stock relative to the cumulative total returns of the Nasdaq Composite Index and the Nasdaq Biotechnology Index.
An investment of $100 is assumed to have been made in our common stock and each index on December 8, 2017 (the first day of trading of our common stock) and its relative performance is tracked through December 31, 2022.
4 unchanged sentences
Use of Proceeds from Registered Securities
−Removed: In January 2020, we sold 9.0 million shares of common stock (inclusive of shares sold pursuant to an overallotment option granted to the underwriters in connection with the offering) through an underwritten public offering at a price of $23.00 per share for aggregate net proceeds of approximately $193.9 million .
−Removed: There has been no material change in the planned use of the net proceeds from the follow-on public offering as described in the Registration Statement.
−Removed: We invested the funds received in short-term, interest-bearing investment-grade securities and government securities.
+Added: In October 2022, we sold $11.9 million shares of common stock (inclusive of shares sold pursuant to an overallotment option granted to the underwriters in connection with the offering) through an underwritten public offering at a price of $26.50 per share for aggregate net proceeds of approximately $296.2 million.
+Added: There have been no material changes in the planned use of the net proceeds from the follow-on public offering as described in the Registration Statement.
+Added: We have invested or plan to invest the funds received in short-term, interest-bearing investment-grade securities and government securities.
Issuer Purchases of Equity Securities
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.